InVivo Therapeutics Holdings Corp
NVIV
NVIV was delisted on the 12th of February, 2024.
12 hedge funds and large institutions have $482K invested in InVivo Therapeutics Holdings Corp in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 4 closing their positions.
43% more capital invested
Capital invested by funds: $337K → $482K (+$145K)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$373K |
| 2 |
Renaissance Technologies
New York
|
+$84.5K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.2K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$13.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$13K |
| 2 |
PWM
Paulson Wealth Management
Wheaton,
Illinois
|
-$6K |
| 3 |
NCM
Next Capital Management
New York
|
-$1K |
| 4 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$249 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
1
Perkins Capital Management
Wayzata,
Minnesota
| $253K | +$373K | +1,500 | New |
|
|
2
Renaissance Technologies
New York
| $166K | +$84.5K | +340 | +53% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $19K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $10K | +$10.4K | +42 | +233% |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $10K | +$14.2K | +57 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| $9K | +$13.7K | +55 | New |
|
|
ICM
7
IMS Capital Management
Portland,
Oregon
| $5K | +$7.71K | +31 | New |
|
8
BlackRock
New York
| $4K | – | – | – |
|
9
Northern Trust
Chicago,
Illinois
| $3K | – | – | – |
|
10
Geode Capital Management
Boston,
Massachusetts
| $2K | – | – | – |
|
11
Morgan Stanley
New York
| $1K | – | – | – |
|
|
BCM
12
Bridgeway Capital Management
Houston,
Texas
| – | -$13K | -33 | Closed |
|
|
PWM
13
Paulson Wealth Management
Wheaton,
Illinois
| – | -$6K | -15 | Closed |
|
|
NCM
14
Next Capital Management
New York
| – | -$1K | -2 | Closed |
|
|
VFA
15
Valeo Financial Advisors
Carmel,
Indiana
| – | -$249 | -1 | Closed |
|
NVIV Hedge Fund Activity: Q4 2019 in Review
12 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q4 2019, worth a combined $482K — up 43% from $337K a quarter earlier.
Fund positioning in NVIV was balanced in Q4 2019: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Perkins Capital Management, opening a new position worth an estimated $373K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $13K sold.
- 12 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $482K of InVivo Therapeutics Holdings Corp stock for Q4 2019, up 43% quarter-over-quarter.
- 4 funds opened new InVivo Therapeutics Holdings Corp positions in Q4 2019 and 4 closed out, a net change of 0 holders.
- The largest InVivo Therapeutics Holdings Corp buyer in Q4 2019 was Perkins Capital Management, an estimated $373K added.
- The largest InVivo Therapeutics Holdings Corp seller in Q4 2019 was Bridgeway Capital Management, an estimated $13K sold.
Based on aggregated 13F filings for Q4 2019.